Cover Image
市場調查報告書

Jyant Technologies, Inc. - 產品平台分析

Jyant Technologies, Inc. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 354956
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Jyant Technologies, Inc. - 產品平台分析 Jyant Technologies, Inc. - Product Pipeline Review - 2016
出版日期: 2016年02月24日 內容資訊: 英文 29 Pages
簡介

Jyant Technologies, Inc.總公司設立於美國,正在進行與搭配診斷並用的新治療藥之開發。開發平台有抗趨化素及抗趨化素受體,趨化素受體蛋白質的拮抗劑等產品,適應症有固態腫瘤,耐荷爾蒙性的胰臟癌症等。

本報告提供Jyant Technologies, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Jyant Technologies, Inc. 的基本資料

  • Jyant Technologies, Inc. 概要
  • 主要資訊
  • 企業資料

Jyant Technologies, Inc. :R&D概要

  • 主要的治療範圍

Jyant Technologies, Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Jyant Technologies, Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Jyant Technologies, Inc. :藥物簡介

  • JT-02
  • alvocidib hydrochloride
  • cisplatin
  • JT-03
  • JT-04
  • JT-05
  • JT-06
  • JT-07
  • JT-08
  • Peptide to Antagonize Leptin Receptor II for Breast Cancer
  • resveratrol

Jyant Technologies, Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Jyant Technologies, Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC07962CDB

Summary

Global Markets Direct's, 'Jyant Technologies, Inc. - Product Pipeline Review - 2016', provides an overview of the Jyant Technologies, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Jyant Technologies, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Jyant Technologies, Inc.
  • The report provides overview of Jyant Technologies, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Jyant Technologies, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Jyant Technologies, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Jyant Technologies, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Jyant Technologies, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Jyant Technologies, Inc.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Jyant Technologies, Inc. Snapshot
    • Jyant Technologies, Inc. Overview
    • Key Information
    • Key Facts
  • Jyant Technologies, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Jyant Technologies, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Jyant Technologies, Inc. - Pipeline Products Glance
    • Jyant Technologies, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Jyant Technologies, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Jyant Technologies, Inc. - Drug Profiles
    • JT-02
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • alvocidib hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • cisplatin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-03
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-04
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-05
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-07
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JT-08
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peptide to Antagonize Leptin Receptor II for Breast Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • resveratrol
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Jyant Technologies, Inc. - Pipeline Analysis
  • Jyant Technologies, Inc. - Pipeline Products by Target
  • Jyant Technologies, Inc. - Pipeline Products by Route of Administration
  • Jyant Technologies, Inc. - Pipeline Products by Molecule Type
  • Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action
  • Jyant Technologies, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Jyant Technologies, Inc., Key Information
  • Jyant Technologies, Inc., Key Facts
  • Jyant Technologies, Inc. - Pipeline by Indication, 2016
  • Jyant Technologies, Inc. - Pipeline by Stage of Development, 2016
  • Jyant Technologies, Inc. - Monotherapy Products in Pipeline, 2016
  • Jyant Technologies, Inc. - Phase II, 2016
  • Jyant Technologies, Inc. - Preclinical, 2016
  • Jyant Technologies, Inc. - Pipeline by Target, 2016
  • Jyant Technologies, Inc. - Pipeline by Route of Administration, 2016
  • Jyant Technologies, Inc. - Pipeline by Molecule Type, 2016
  • Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action, 2016

List of Figures

  • Jyant Technologies, Inc. - Pipeline by Indication, 2016
  • Jyant Technologies, Inc. - Pipeline by Stage of Development, 2016
  • Jyant Technologies, Inc. - Monotherapy Products in Pipeline, 2016
  • Jyant Technologies, Inc. - Pipeline by Target, 2016
  • Jyant Technologies, Inc. - Pipeline by Molecule Type, 2016
  • Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action, 2016
Back to Top